Friday, April 29, 2011

Bethel Finances: Gasoline prices to rise 3% Saturday night

www.bethelfinance.com

Bethel Finance news:

The price of self-service 95 octane gasoline will rise 3.11% - NIS 0.23 per liter - to NIS 7.62 per liter at midnight Saturday, April 30. The price in Eilat (where there is no VAT) will be NIS 6.59 per liter. The full service surcharge is unchanged.

The Ministry of National Infrastructures said that the 9% rise in the price of CIF La Vera trade prices for fuels in the Mediterranean basin, which accounts for 39% of the price of gasoline in Israel, was responsible for the price hike.

In addition, the government raised the excise on gasoline by 1.1%, or NIS 0.03 per liter. Since Prime Minister Benjamin Netanyahu responded to public pressure on fuel prices in February and rescinded the excise hike introduced a month earlier, the price of gasoline has climbed 8.4%.

The price of oil has climbed to $113 per barrel as the upheavals in the Middle East continue, and the civil war in Libya disrupted supplies.

Bethel Finances: EU regulator probes Teva sleep drug deal

www.bethelfinance.com

Bethel Finance news:

European Union antitrust regulators announced on Thursday that they are investigating allegations that Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) and Cephalon Inc. worked together to keep a generic version of sleep-disorder drug Provigil out of the European market. Provigil had sales of $1.12 billion for Cephalon in 2010.

In 2005, Teva and Cephalon settled patent disputes relating to Provigil - which is also known as Modafinil in the US and UK.

As part of that deal, Teva agreed not to sell its generic version of Provigil in the EU as well as Iceland, Liechtenstein, and Norway before Oct. 2012, the EU's antitrust regulators claim.

The European Commission is now investigating whether that agreement broke EU antitrust regulations and had the "object or effect" of keeping generic Provigil out of the European market.

"Pay-for-delay" deals between brand-name and generic drug makers have come under scrutiny from competition authorities in both North America and Europe. Regulators are concerned that such agreements harm consumers who have to pay much higher prices for the brand-name drugs even after patents expire.

The US Federal Trade Association filed a lawsuit against Cephalon in 2008, alleging the company paid off potential competitors to keep a cheaper version Provigil off the market.

Teva said, "We confirm that we have received notification from the EU authorities that they are planning to open proceedings relating to alleged violations of competition rules. The authority wants to clarify matters regarding the 2005 commercial agreement between Teva and Cephalon. The notification explicitly says that the initiation of proceedings does not indicate any legal violations. Teva will continue cooperating with the European authorities and all other authorities and we believe that we worked within the law in every instance."

Teva's share price rose 0.33% on Nasdaq on Thursday to $46.13, giving a market cap of $41.42 billion.

Wednesday, April 27, 2011

Bethel Finances: Getty Images acquires PicScout for $20m

www.bethelfinance.com

Bethel Finance news:
Getty Images Inc. has acquired image copyright solutions developer PicScout Inc. for $20 million.

This is a successful exit for PicScout, which raised just $1 million from Yair Goldfinger, a co-founder of Mirabilis, and Lenny Recanati. The company's annual turnover is estimated at $5 million, and it is believed to be profitable.

PicScount filed a prospectus with the Israel Securities Authority to raise $5-10 million at a company value of $20-30 million in an IPO on the Tel Aviv Stock Exchange (TASE) in September 2010, but withdrew the plan.

PicScout will continue to operate independently following the acquisition, and no major personnel changes are expected. The Herzliya-based company has 60 employees.

PicScout CEO Offir Gutelzon and chairman Eyal Gura founded the company in 2002. Gura has also invested in another start-up, The Gift Project, co-founded by his brother, Ron Gura.Last month, he marked up another exit with the sale of PicApp Ltd., which he founded in 2008, and sold to Indian digital marketing company Ybrant Digital Ltd.

PicScout's technology identifies the digital fingerprint of images appearing online, even if they have been blurred or edited. The company has two products: ImageTracker, which locates the use of images online and reports it to the copyright owner; and ImageExchange, an add-on to Firefox and Explorer browsers, which can identify in real time copyrighted images and offer the users an option to buy them.

Bethel Finances: Bank of Israel limits variable rate mortgages

www.bethelfinance.com

Bethel Finance news:

The Bank of Israel today published a new directive to limit variable interest mortgages. The directive will apply to new loans approved from May 5, 2011.

The directive limits the part of a mortgage issued at a variable interest rate to one third of the total mortgage granted by a bank to the borrower, down from 76% today. The Bank of Israel said that the new measure would make the average mortgage 1% more expensive. The limit applies on new variable interest rate mortgages where the interest rate is likely to change in a period of less than five years.

The directive also requires banks to advise customers with variable interest rate mortgages linked to the prime interest rate where the indexed component of the loan is at least one-third of the total loan, about the possible effects of a rise in the interest rate on their monthly payments, and how to assess and reduce the risk.

The Bank of Israel published the new draft directive because of continued trends in the housing market, in particular the significant volume of variable interest rate mortgages, which involve an inherent risk to borrowers. Specifically, the central bank points to the risk that higher interest rates will affect borrowers' ability to meet their monthly payments, jeopardizing the banking system. The risk is real given that the Bank of Israel is raising interest rates.

The Bank of Israel notes that many financial crises that have occurred in other countries began with housing credit granted under terms that did not reflect the risks developing in the sector, and that were inappropriate in light of the rapid rise in housing prices. The Bank of Israel said that the new directive was intended to prevent a similar development in Israel, in the interest of the public and the whole financial system.

Tuesday, April 26, 2011

Bethel Finances: Mortgage loans about to become more expensive

www.bethelfinance.com

Bethel Finance news:

Housing prices haven't stopped rising and so the Bank of Israel is planning another move, hoping to prick any nascent real-estate bubble before it fully forms.

This week, possibly even today, the central bank will be limiting mortgage loans at the prime rate of interest to 40% of the value of the purchased home, down from 60% today.

The prime rate of interest is the reference rate used by the banks. With Bank of Israel interest at 3%, the prime rate was 4.5%.

This will be the third step the Bank of Israel has taken with hopes of cooling down the raging Israeli real estate market.

The first was in May 2010, when the Bank of Israel capped the maximum mortgage loans bearing the prime rate of interest at 60% of the value of the purchased home in May 2010, down from 80% beforehand.

In October 2010, the Bank of Israel - again with the idea of making mortgages more expensive - ordered the banks to set aside a bigger proportion of capital when making big mortgage loans.

The central bank, led by Governor Stanley Fischer, had considered lowering the cap on mortgage loans bearing prime interest a month ago. But then - at the end of March - the Bank of Israel decided to raise its interest rate for April by 0.5% (to 3% ), and the governor decided to hold off on the latest mortgage decree.

Fischer spent the Seder and Passover holiday in the United States with his family. However, he was back in the early hours of Thursday morning and by 9 AM that day, was at the Bank of Israel to conduct the monetary meeting.

On Sunday the central bank announced that its rate of interest would remain unchanged for May at 3%. The break in interest rate increases, after three straight months of hikes, prepared the groundwork for the latest move to rein in mortgage lending.

The central bank could theoretically have made its announcement about mortgages on Sunday, together with the interest rate announcement. But it reportedly decided to hold off on the announcement until after the Passover holiday, in order not to spoil the mood.

Still, the signs were there. In its interest rates announcement on Sunday, the central bank devoted a great deal of attention to the increase in housing prices and the mortgages market.

According to the housing survey by the Central Bureau of Statistics, home prices rose at an annualized pace of 1.7% in January and February. Over the last 12 months, home prices have increased by 16.1%, the data shows.

Meanwhile, another index tracking the price of rent (which, unlike the housing survey, is included in the consumer price index ) has increased by 6.4% in the last 12 months.

In the last 12 months, according to the Bank of Israel, about NIS 50 billion worth of mortgage loans were given.

Interest on mortgages continued to rise in April, partly because of the Bank of Israel's rate hikes. Meanwhile, the smart money is predicting a rate hike for May, if the consumer price index in April does as widely expected - rises a lot. The Bank of Israel is predicting that the CPI will have increased by 0.8% in April, which will all but force the governor to raise the central bank rate of interest.

Bethel Finances: Novamed unveils ‘home heart-attack test kit’

www.bethelfinance.com

Bethel Finance news:

Dr. Emil Katz, founder and CEO of Israeli start-up Novamed, says everyone should have a heart attack test at home, to be on the safe side. “When you do the test, it says, ‘Rush to hospital,’ or ‘Carry on as usual.’ I don’t understand why the market hasn’t demanded this up to now.”

The answer is clear: Many people would gladly keep such a test at home, but it doesn’t exist yet. So Katz plans to launch one in a few months time, via pharmacies in Israel.

If that declaration had come from any other entrepreneur, it might have sounded too ambitious. But Katz has a history of developing diagnostic products that are rapidly adopted for clinical use. Novamed has developed many of the most popular diagnostic tests sold in Israel.

It has annual sales of $10 million, half of which derives from Israel, and it is profitable. The company employs 60 people.

Katz started developing is products 20 years ago, for Israel’s then undeveloped diagnostics market. Among other things, he developed the urine test cup with built-in test tube used by the General Health Fund for all its tests.

Novamed sells about 100 diagnostic products, most of them raw materials for generic molecular tests or tests that are easy to develop, but some of them are patent protected.

The company specializes in developing quick tests that give results within hours, compared with a day to two days for competing products.

Canadian fund Riverside bought Novamed for $10 million in 2007.

“Since then we have only grown,” Katz told Globes. I even slightly regret that I sold, but some of the partners wanted liquidity.

Katz was first interviewed by Globes in early 2010, when he told how Riverside had given him a blank check to buy Israeli diagnostics companies.

Despite that, no companies have been acquired. Katz says that no technology was found that suited the fund’s product pipeline.

The heart attack test is Novamed’s most exciting product. Today, patients suspected of being in the throes of a heart attack undergo a test in hospital to detect an enzyme called Troponin T. Its presence indicates that a heart attack has taken place.

“The Troponin test is a Roche patent,” says Dr. Igal Ruvinsky, Novamed's head of R&D. “However, a few companies have discovered Troponin I, which is no less effective for detecting heart attacks. There is no patent on its use, and various companies produce it in various ways.”

Novamed has also developed a test based on Troponin I, and on another material found to be effective in diagnosing heart attacks in recent years.

The two tests combined make it possible to detect more than 90% of patients with the disease, and, according to the company, they do so several hours earlier. “Heart attacks are perceived as something that happens in an instant, but in fact they develop over a period of days,” Katz says.

Just one drop In the past few years, self-diagnosis heart attack tests have been launched in China and in some European countries, but, according to Katz and Ruvinsky, they don’t offer a real solution to the problem.

What is unique about Novamed’s test is that it can be carried out on just a single drop of blood. This is what makes possible the transition from a test that only a qualified hospital nurse can carry out, to a blood test that anyone can do at home by pricking a finger.

“When a person suspects that they are having a heart attack, and they are in pain, perspiring, and trembling, it’s impossible to extract four drops of blood from their finger,” says Katz. “A test using one drop is the only possibility for launching a home test, or even a fast test for a hospital that does not require taking blood from a vein.”

How have you managed to base the test on just one drop of blood? Ruvinsky: “This is thanks to the filters in our test kit. They leave the blood cells behind, and only allow the blood fluid to flow into the test window. In the other tests, the red blood cells are torn and pour their contents into the test window, which makes it impossible to detect low levels of the enzyme. These tests are accurate only when the person is already at the height of the attack.”

Within 15 minutes at most, two lines appear in the test window, as in a pregnancy test: a control line and a test line indicating the presence of the enzyme. But even if the test is negative, it’s not possible to relax. “If the patient still feels unwell, he or she should still go to hospital. Alternatively, the test can be repeated after a while.”

In a trial carried out at Wolfson Hospital on 75 participants who came to the Accident and Emergency Department with heart attack symptoms, the company’s Troponin test identified 83% of the patients, the FABP test identified 89%, and combined, the tests identified 94% of patients in the early stages of the disease.

If the test does not rule out a heart attack, hospitals will still be flooded with hypochondriacs, so what have you achieved? Katz: “Anyone who is really having a heart attack and tests positive will not be complacent and will go to hospital immediately. That is much more important than weeding out the hypochondriacs.”

In the initial stage, planned to start in another few months, the product will be sold in Israeli pharmacies, and marketing activity will begin in Europe, but it is still a long way from approval by the US Food and Drug Administration. “For that, we will need to team up with a big company.”

Apart from this, Novamed is now setting up a company that it will partly own, in Russia, to produce and sell its products there. “In most western countries, there are already factories producing test like ours. In Russia, like in Israel 20 years ago, they are still concocted in the hospitals in an inefficient and not very professional way.”

In the US and Europe, Novamed is not setting up factories. In those places, it will only sell its patent-protected products. “The current focus is on Russia and the US. At this stage, that’s enough for me. Combined, these two markets have 500 million people. I manage to live well here, with a market of eight million.”

Bethel Finances: Obama urges Turkey to improve Israel relations

www.bethelfinance.com

Bethel Finance news:

In a telephone conversation with Turkish Prime Minister Recep Tayyip Erdogan yesterday US President Barack Obama expressed his hope to Prime Minister Erdogan that Turkey and Israel will find opportunities to improve their relations in the interest of regional stability. The readout of the conversation on the White House website did not mention Erdogan's reply.

Obama and Erdogan discussed developments in the Middle East as part of their continuing consultations. The President expressed appreciation for Turkey’s ongoing humanitarian efforts in Libya and its participation in the NATO No-Fly Zone and Arms Embargo operations. They agreed that attacks against civilians must stop and that Libyan leader Muamar Qaddafi must step down and depart Libya permanently in order for there to be a lasting solution that reflects the will of the Libyan people. They also expressed their deep concern about the Syrian government’s unacceptable use of violence against its own people, and agreed that the Syrian government must end the use of violence now and promptly enact meaningful reforms that respect the democratic aspirations of Syrian citizens.

Bethel Finances: Bank of Israel leaves interest rate unchanged

www.bethelfinance.com

Bethel Finance news:

The Bank of Israel has left the interest rate for May unchanged at 3%. Most analysts had predicted that Governor of the Bank of Israel Prof. Stanley Fischer, who raised the interest rate by 0.5% last month to 3%, would raise the interest rate by a further 0.25%, though some analysts had suggested he would keep it unchanged.

In citing the main considerations behind its decision, the Bank of Israel mentioned the appreciation of the shekel and lower inflationary expectations.

The Bank of Israel noted, "The recent appreciation of the shekel and the recent increases in the interest rate are expected to moderate the rate of inflation in the coming months."

The bank added, "Inflation expectations for the next twelve months derived from the capital market declined, due in part to the increase in the interest rate for May. However, at 3.1%, similar to the average of the forecasters’ expectations which did not change this month, the expectations are still above the upper limit of the inflation target range. Inflation expectations for periods longer than a year also declined, and most are now within the target range."

On housing prices the Bank of Israel said, "House prices continued to increase this month, and in the last twelve months have risen by 16.1%. The balance of housing credit increased by 12.8% in the twelve months to February 2011. About 80% of housing loans granted in March were at floating interest rates. Against the background of these developments, the Bank of Israel is considering the introduction in the near future of additional measures in the housing credit field."

Bethel Finances: Citi: BOI needs to be aggressive on mortgages

www.bethelfinance.com

Bethel Finance news:

Citi Capital Markets believes that, after unexpectedly keeping the interest rate for May unchanged at 3% on Sunday, the Bank of Israel's upcoming additional measures in the housing credit field will "need to be pretty aggressive to keep the Bank's behavior credible." Citi says that the Bank of Israel's failure to raise rates on Sunday could be taken by the market as a sign of inconsistency, and that could create some upside risks to inflation expectations.

Citi analyst David Lubin notes that he was among the analysts who had predicted that the Bank of Israel would raise the interest rate by 25 basis points, because inflation is currently running at 4.3%, way above the 3% target ceiling, and inflation targets indicate that inflation will stay above the ceiling for the rest of 2011; economic activity seems very robust; and the housing and labor markets still seem tight.

Lubin says that the Bank of Israel seems to have a two-fold strategy, relying on the shekel and on macro-prudential measures. He says that Bank of Israel's argument in favor of unchanged rates on Sunday seems to hinge considerably on the impact of the recent appreciation of the shekel and that it is probably also counting on the impact of (as-yet-unannounced) measures to squeeze mortgage credit.

Bethel Finances: Netanyahu backs Treasury on doctor's strike

www.bethelfinance.com

Bethel Finance news:

Prime Minister Benjamin Netanyahu today met with top Ministry of Finance and Ministry of Health officials as the Israel Medical Association threatens to renew the doctors' strike. Netanyahu reportedly gave full support for the Ministry of Finance's demand that in exchange for any deviation from the public sector salary agreement - a 7.25% pay hike over four years - doctors will, for the first time, be required to punch a clock.

The doctors are still demanding a 50% increase to their basic salaries, and reject the demand to punch a clock. A source at the meeting said, "Netanyahu basically said what he has always said, 'They give, they'll get'."

Ministry of Finance officials told Netanyahu of the doctors' demand to shorten shifts for specialists to 18 hours from 26 hours. To meet this demand without increasing the number of shifts per month, the ministry insisted that specialists also be required to add positions.

The Ministry of Health is prepared to reduce shifts by two hours, while the Medical Association is demanding a large increase in fees for shift work by specialists - a demand that would prevent hospital administrators from increasing the number of shifts because of a lack of funding.

The source said that Netanyahu supports the positions of the Ministry of Finance and the Ministry of Health that most of the cost of an agreement with doctors be used to finance doctors in the periphery and for specialists in fields with shortages.

On Wednesday, the Medical Association will hold a large demonstration in the Rose Garden by the Knesset - a sign that it is planning to resume its fight. Representatives from the Medical Association and the Ministry of Finance are due to meet tonight, but sources doubt that any progress will be made and work disruptions at government hospital will likely resume on Sunday.

Bethel Finances: DMoody's leaves Israel's rating unchanged on security fears

www.bethelfinance.com

Bethel Finance news:

Moody's Investment Services has reiterated its A1 government debt rating with a "Stable" outlook for Israel.It says that the rating balances the country's high levels of economic, institutional, and financial strength, as well as its geopolitical challenges.

The Ministry of Finance hopes that Moody's will upgrade Israel's debt rating by the end of the year or in early 2012. For now, Moody's is making no change in its debt rating, nor hinting at any change in the foreseeable future.

Moody's VP sovereign risk group Anthony Thomas said, "The Israeli economy is resilient and dynamic, and the macroeconomic policy framework is coherent." He cautions, however, "We are less concerned about Israel's fiscal well-being than we are about the potentially negative consequences for investment and territorial security," citing Israel's geopolitical challenges and its good track record in coping with them.

Moody's notes that Israel's government debt figures were relatively unaffected by the global crisis, and are already improving. The debt-to-GDP ratio fell slightly below its pre-crisis level by the end of 2010.

Moody's adds that Israel's high-tech exports based economic model is performing well and underpins favorable medium-term growth prospects. The new Bank of Israel Law (5770-2010) and additional limits on fiscal spending and deficits strengthen already robust institutions.

However, Moody's warns that the unrest across the Middle East highlights the regions geopolitical risks. While the unrest is motivated by internal political discontent, it could potentially have fiscal repercussions for Israel if defense spending has to be increased.

Bethel Finances: XTL seeks FDA orphan drug status for blood cancer drug

www.bethelfinance.com

Bethel Finance news:

XTL Biopharmaceuticals Ltd. (Pink Sheets:XTLBY); TASE:XTL) has applied to the US Food and Drug Administration (FDA) for orphan drug status for its erythropoietin (EPO) drug for the treatment of multiple myeloma blood cancer. The drug is undergoing a Phase II clinical trial.

XTL has a patent for EPO that is valid until 2019.

Orphan drug status applies to drugs for treating diseases that affect a small number of people; the FDA sets a figure of a disease affects fewer 200,000 persons a year. FDA orphan status grants various incentives for developing these drugs, including shortened approval procedures, tax breaks on R&D costs, and financing assistance. If the drug is the first to reach market, it also receives seven years exclusivity.

XTL closed at $0.31 in New York yesterday, giving a market cap of $22 million, and rose 6.5% on the TASE today to NIS 0.64.

Bethel Finances: Defense co Arotech files $35m Nasdaq shelf prospectus

www.bethelfinance.com

Bethel Finance news:

Defense company Arotech Corporation (Nasdaq: ARTX) has filed a shelf prospectus with the US Securities and Exchange Commission (SEC) to raise up to $35 million in an offering of shares, warrants, or bonds. The company will use proceeds from the offerings for general business purposes, R&D, production, and acquisitions.

Arotech had just $6.3 million in cash at the end of 2010, and an additional $1.8 million in restricted deposits. The company develops simulators, armor kits for vehicles, and zinc-air and lithium batteries through its units in Israel and the US. Its armor kits unit is located in Lod.

In the prospectus, Arotech mentioned the investment risks, which include its accumulated debt - $170.7 million, since it was founded in the early 1990s. The company added that the employment contract with chairman and CEO Robert Ehrlich expires at the end of the year.

Arotech's revenue fell 1% to $73.7 million revenue in 2010 from $74.5 million, and its net loss narrowed 64% to $1.1 million ($0.18 per share) from $3.1 million. At the conference call following the publication of the results, Ehrlich said that the company was examining new fields of activity, including medical imaging and the development of batteries for storing solar and wind-generated energy.

Arotech's share price rose 3.2% yesterday to $1.31, giving a market cap of $19 million.

Isra-Mart srl : FDA approves Taro's Canadian pharmaceutical facility

www.bethelfinance.com

Bethel Finance news:

Taro Pharmaceutical Industries Ltd. (Pink Sheets: TAROF) can resume regular production at its Canadian manufacturing facility, after the US Food and Drug Administration (FDA) approved the facility, following a re inspection of the site in February 2011. The facility is located in the Toronto suburb of Brampton.

Taro said that the issues raised in the FDA warning letter of February 5, 2009 are considered to be resolved.

The FDA has been tightening its enforcement in recent years, sending warning letters to many pharmaceutical companies about faults found in their manufacturing facilities. The inspection at the Brampton facility related to flaws in the production of an anti-itch and acne cream Fluocinonide and for ringworm cream Cicloopirox Olamine.

Taro interim CEO James Kedrowski said, “We have worked diligently at the Brampton facility to resolve the issues noted in the last inspection and are pleased that our efforts have brought the facility back into good standing with the Agency. We are dedicated to developing and manufacturing quality products for our customers while meeting and exceeding all Good Manufacturing Practices (GMP) standards set by the FDA and Health Canada."

Taro's share price closed at $14.40 yesterday, giving a market cap of $566 million.

Bethel Finances: Unchanged rate weakens shekel against dollar

www.bethelfinance.com

Bethel Finance news:

The shekel-dollar exchange rate rose 0.41% in early inter-bank trading today to NIS 3.419/$, after Governor of the Bank of Israel Prof. Stanley Fischer left the interest rate for May unchanged at 3% on Sunday, before the second Passover holiday. The shekel-euro exchange rate rose slightly by 0.03% to NIS 4.985/€.

In international markets, the dollar weakened against the euro to $1.452/€ and against the Japanese yen to ¥81.705.

The Bank of Israel is expected to announce new macro-prudential measures to restrain demand in the real estate market, including restricting use of prime interest rate mortgages and capping bank mortgages to 50% of a home's value, forcing buyers to provide half of a home's equity from their own sources.

In global forex markets, traders are waiting for Federal Reserve Board Chairman Ben S. Bernanke to announce the US interest rate tomorrow. He is also expected not to extend the Fed's purchases of US T-bills, marking the end of the expansionist monetary policy. He will convene a special press conference to discuss the importance of the interest rate decision.

Bethel Finances: Deutsche Bank: Markets overreacted on Teva

www.bethelfinance.com

Bethel Finance news:

Deutsche Bank says the 8.5% fall in the share price of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) on Thursday in response to Biogen Idec Inc. (Nasdaq: BIIB) news about its oral multiple sclerosis drug, BG-12, was overdone. Deutsche Bank reiterates its "Buy" recommendation for Teva with a target price of $64.

Deutsche Bank says that BG-12's data appears to be superior to that of Teva's oral multiple sclerosis drug, Laquinimod, but that there is no safety data about BG-12. However, "it is difficult to compare data from different trials due to differences in endpoints and patient populations. And until we see head-to-head data, full safety data, and publication of the Define study in a peer-review setting, drawing definitive conclusions can be risky."

Deutsche Bank concludes that Teva's current share prices is close to a worst-case scenario in which generic versions of Copaxone come on the market in the near term, but there is still considerable upside to Teva's shares.

Merrill Lynch is not so sanguine. On Friday, it slashed its target price for Teva to $58 from $65, although it reiterated its "Buy" recommendation. It says that there is no realistic chance that Copaxone will disappear.

Teva's share price rose 1.6% on Nasdaq yesterday to $45.71, giving a market cap of $42.95 billion, but fell 5.7% in early trading on the TASE to NIS156.10 - the first day of trading since Biogen's news.

Bethel Finances: Teva drags market down from record

www.bethelfinance.com

Bethel Finance news:

The Tel Aviv Stock Exchange (TASE) fell today. The Tel Aviv 25 Index fell 0.65% to 1,333.14 points, the Tel Aviv 100 Index fell 0.76% to 1,212.36 points, and the BlueTech 50 Index fell 0.34% to 291.59 points. Turnover was NIS 1.65 billion.

The TASE fell across the board today, with the exception of the Tel Bond indices. Most analysts believe that the TASE will continue rise, albeit slowly, even after reaching a new all-time high, and they therefore do not advise selling shares.

In the bond market, long-term Shahar unlinked government rose by up to 0.2% and long-term Galil CPI-linked rose by up to 0.4%. The corporate bond benchmark Tel-Bond 20 Index rose 0.44%.

In the foreign currency market, the shekel-dollar representative exchange rate rose 0.25% to NIS 3.413/$, and the shekel-euro representative exchange rate rose 0.04% to NIS 4.986/€.

In the stock market, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) fell 4.7% on the day's largest turnover of NIS 439 million - over a quarter of the day's total turnover - in a delayed reaction to last Thursday's plunge on Nasdaq. Bank Hapoalim said today, "The capital market's reaction was overblown." Psagot Investment House Ltd. said the extreme drop in the share price increased the chances of profits.

Oil Refineries Ltd. (TASE:ORL) rose 0.6%.

Some technology shares continue to favorably stand out. Mellanox Technologies Ltd. (Nasdaq:MLNX; TASE:MLNX) rose 2.7%, EZchip Semiconductor Ltd. (Nasdaq: EZCH; TASE:EZCH) rose 2.3%, Magic Software Enterprises Ltd. (Nasdaq: MGIC; TASE: MGIC) rose 5.5% ahead of Friday's publication of its first quarter financials.

Alony Hetz Property and Investments Ltd. (TASE: ALHE) subsidiary Amot Investments Ltd. (TASE:AMOT) rose 0.3% to NIS 10.74. Leader Capital Markets gave the real estate company an "Outperform" recommendation with a target price of NIS 11.50.

Bethel Finances:Better Place to begin electric car sales in August

www.bethelfinance.com

Bethel Finance news:

Better Place will begin selling electric vehicles in Israel in August, "Yediot Ahronot" reported this morning.

The company, managed by Shai Agassi together with Ofer Brothers controlled Israel Corp. (TASE:ILCO) has reportedly closed its visitors center near the Glilot Junction, north of Tel Aviv, and is converting it into a sales center that will offer the company's first electric car - the Renault Fluence ZE - to Israeli customers.

The sales center, which will be Better Place's "flagship store," will open in a huge warehouse at the Glilot Junction that formerly served as a fuel storage warehouse. The test track built for the visitors center will remain so that customers can try out the electric vehicle.

The price of the cars has not yet been published. Better Place is expected to reveal details about prices and usage contracts next month.

Shai Agassi has previously pledged that the monthly cost for purchase, use, maintenance and fuel will be lower than the current cost of a similar gasoline fuelled car. Another significant factor will be the tax incentive with only 10% purchase tax on electric vehicles compared with 90% on regular cars.

Bethel Finances: Google offers NIS 7m for modu's patents

www.bethelfinance.com

Bethel Finance news:

Google Inc. (Nasdaq: GOOG) has offered NIS 7 million for the patents of failed mobile phone developer modu. Google submitted the offer to the Tel Aviv District Court, which is handling modu's liquidation. Google topped the previous offer of NIS 5 million made by Kensington Technology Corporation in late March.

In December 2010, the court appointed a receiver for modu, founded by Dov Moran, and the company's employees petitioned for its liquidation.

modu owes its creditors, including banks, tens of millions of shekels, after losing NIS 450 million. After failing to hold an IPO on the Tel Aviv Stock Exchange (TASE), financially-strapped modu ceased operations and began the sale its assets. The company registered over 100 patents in its three years of operations, and they constitute its main asset.

modu receiver Adv. Hanit Nov was about to submit Kensington's offer for approval by the court when a higher bid was received at the last moment, and she petitioned the court for a new pricing round. Today it was learned that the offer was made by Google.

Bethel Finances: Alcatel Lucent opens global cloud unit in Israel

www.bethelfinance.com

Bethel Finance news:

Alcatel Lucent SA (NYSE; Euronext: ALU) today officially launched its global cloud computing center in Israel, keeping its promise made when it recently closed its optics R&D center and fired scores of employees. The new business unit will include an R&D center that will focus on developing cloud-based smart, open, and secure architectures for communications carriers worldwide.

Alcatel Lucent appointed Dor Skuler, 34, as VP cloud enablement to manage the new center. He said, "The decision to open the cloud unit in Israel was made after a thorough examination of several alternative sites in the world. The reasons include Israel's high-quality personnel and software engineers, its entrepreneurial spirit, and existing cloud concentration. The new unit in Israel will operate as an internal start-up in terms of speed, flexibility, and rapid decision-making. It will have scores of employees by the end of 2011."

Skuler was previously Alcatel Lucent VP strategy and business development. He told "Globes" that the new center will be more than just R&D, and that he is also looking for production and operations managers. He added that the center would employ scores of people depending on demand and the market, since it was a global operation managed from Israel.

Skuler said that the decision to set up the center in Israel was related to the fact that the country has a critical mass of people with the understanding and capabilities in IT and telecommunications.

Friday, April 22, 2011

Bethel Finances: Israel Corporation unit reports biomass fuel breakthrough

www.bethelfinance.com

Primus Green Energy Ltd., a US subsidiary of Israel Corporation’s (TASE: ILCO) renewable energy unit IC Green Energy Ltd., reports that it has developed a process to convert agricultural biomass into standard automotive fuels at a competitive production cost compared with the price of oil. Primus GE uses agricultural residues that do not compete with food crops.

The final product is 93 octane gasoline, with the energy capabilities and characteristics of regular gasoline for vehicles and industry. There is no need for engine customization and it can use existing fuel distribution networks. Primus GE says that its biofuel emits 80% less pollution than gasoline refined from oil.

As part of Primus GE’s effort to commercialize its product, it has an engineering services agreement with Lockheed Martin Company (NYSE: LWT), which is seeking biofuel solutions, especially for jet fuel, for the US Department of Defense. Primus GE plans to produce bio-jet fuel.

Primus GE is also negotiating a letter of intent with a major US engineering company to be the chief contractor to build Primus GE’s commercial plant.

The company has a cooperation agreement with New York-based Landmark Ventures to lead a future financing round. It also has a letter of intent from Tennessee-based Eco Energy Inc., which currently handles 20% of US ethanol and biodiesel commerce, and it is in contact with US agricultural companies to grow biomass on marginal land, and with logging companies for their wood residue.

Primus GE CEO Dr. Moshe Ben-Reuven founded the company and its chairman, Dr. Yom-Tov Samia, is the president of IC Green Energy.

Samia said Wednesday, “Primus GE can produce 2,000 gallons of biofuel at its pilot facility...

Primus GE’s technology could lead to a positive revolution in the fuel industry, and signals a possible rehab from dependence on oil. IC Green Energy was founded in 2007 on the basis of Idan Ofer’s vision to enter the renewal energy field. Fuel production from wood residue is another aspect of this strategy.”

IC Green Energy operates worldwide, including solar energy in Israeli and biofuel development in Germany. Israel Corp, controlled by the Ofer family, invested $105 million in IC Green Energy through the end of 2010.

Bethel Finances: Asphalt additive said to double the lifespan of roads

www.bethelfinance.com

Bethel Finance news:

After its progress was slowed amid Ehud Olmert’s alleged improprieties, Dimona Silica has now won a $6 million order to pave a Chinese highway.

Dimona Silica Industries Ltd. has developed a proprietary asphalt mix for improving roads, which the company hopes will do for it what Copaxone did for Teva Pharmaceutical Industries Ltd., what phosphates did for Israel Chemicals Ltd. and what drip irrigation technology did for Netafim Ltd.

Dimona Silica’s iBind Mix involved the company in Israel’s murky politics, suspicions, and investigations. In 2004, the company was one of the targets of the Investment Promotions Center scandal that involved allegedly improper approvals by then minister of industry, trade and labor Ehud Olmert and his relations with his right-hand man Uri Messer.

State Comptroller Micha Lindenstrauss investigated the affair, and found that Messer opened the door for Dimona Silica founder Ephraim Feinblum to Olmert, who would go on to become prime minister and end his career amid corruption allegations.
In 2004, Dimona Silica needed Olmert’s help because the Investment Promotions Center’s director, Shmuel Mordechai, had reservations about the viability of the venture. No viability, no grant, Mordechai said.

Dimona Silica’s problems began when Olmert intervened and promised the venture a $10 million grant under the Law for the Encouragement of Capital Investments. Olmert’s decision and conduct were subsequently placed under a magnifying glass.

Ultimately, Feinblum handed the reins of Dimona Silica to his son-in-law, Ronen Peled. “We never received most of the grant, and we survived only thanks to money from foreign investors,” Peled told Globes.

“One day, I was sitting in my office and looked at a poster of a car tire on the road, and wondered what would happen if we added silicate to the asphalt preparation process in order to extend the lifespan of tires. I, with no background in chemistry, thought that this would be either genius or idiocy. I didn’t know then that this idea would drive the company forward.”

The company’s Russian investors were skeptical. Peled said, “They laughed amongst themselves, saying in Russian, ‘See, another one who thinks he’s a chemist.’”

Shortly afterwards, chemical experts from the Technion came to Dimona Silica’s plant for a detailed briefing of the concept. They said that it was necessary to examine the mix and its durability, read the professional literature, and work long hours in the lab.

The initial results came a year later, and the news was good. The new additive is based on a mineral deposit found at Nahal Zinn in the Negev and nowhere else in the world. The additive can double the lifespan of an asphalt road, make the driving experience quieter. The asphalt preparation process is more environmentally friendly than regular asphalt because there is no need to heat the asphalt to a high temperature and it cuts emissions of pollutants by 30%. The result is a substantial reduction in costs.

Dimona Silica moved quickly, registered a global patent for its iBind Mix, conducted a series of intensive tests, and paved roads in field tests under the supervision of the Israel Standards Institution.

The Russian investors were regularly updated on the developments, and sent back comments that only satisfied people make.

Peled said, “A crust formed over the wound. The Investment Promotions Center scandal almost killed us, even though we had nothing to do with it. Who would have believed it! We got back on our feet. We’re now looking forward, we want to think about the past as little as possible, especially the bad parts.”

Dimona Silica has already won its first tender, worth $6 million, to pave a road in China. After the pilot on the first road paved with iBind Mix in Israel, Peled said, “This was a historic moment. The mix was perfect. Everyone who drives on this stretch of road will feel the difference. There is simply no noise.”

Dimona Silica is now talking about innovative and breakthrough products based on its proprietary mix and about global markets, ongoing tests of its mix in Europe and the US, and the company’s new factory that will be built within four months in Dimona. The new plant will have a production line and employ at least 50 more people, residents of the Negev.

“The sky’s the limit. We've got something and we have no intention of missing it,” says Peled. “We have more obstacles to pass. We never received most of the government grant. Now that the material is shown to work and is viable from any perspective, there is no reason not to release the money to us. There is no reason for not building here the first production line of the chemicals products industry in Israel for export. We have something to offer, and it will only do good for Dimona and the south.”

Thursday, April 21, 2011

Bethel Finances: Shekel dollar rate dips below NIS 3.4/$

www.bethelfinance.com

Bethel Finance news:

The shekel dollar exchange rate was set down 0.55% at lunch time at NIS 3.405/$, while the euro rose sharply by 0.84% to NIS 4.983/€. After the exchange rate was set, the shekel continued to strengthen and the dollar went below the important psychological threshold of NIS 3.4/$ for the first time in more than 30 months. In the early afternoon the rate was down a further 0.16% at NIS 3.399/$.

On global markets, the major currencies were stable with the dollar fractionally weaker against the euro at $1.457/€.

On Sunday, Bank of Israel Governor Prof. Stanley Fischer will announce the interest rate for May and market sentiment is divided over whether he will keep the rate unchanged or raise it by 25 basis points to 3.25%. Last month Fischer raised the rate by 0.5%.

Clal Finance believes that Israel's strong macroeconomic performance, which indicates continued economic growth, supports a further rise in the interest rate. However, Clal Finance does not think that the Bank of Israel will raise the interest rate on Sunday because any interest rate rise in the US has been put off, and because of the strengthening of the shekel.

Furthermore, inflationary expectations have fallen over the past month to 3.3% from 3.7%, though they are still above the government's annual target range of 1-3%.

Bethel Finances: Asphalt additive claims to double the lifespan of roads

www.bethelfinance.com

Bethel finance news:

Dimona Silica's iBind Mix involved the company in Israel's murky politics, suspicions, and investigations. In 2004, the company was one of the targets of the Investment Promotions Center scandal that involved allegedly improper approvals by then Ministry of Industry, Trade and Labor Ehud Olmert and his relations with his right-hand man Uri Messer.

State Comptroller Micha Lindenstrauss investigated the affair, and found that Messer opened the door for Dimona Silica founder Ephraim Feinblum to Olmert, who would go on to become prime minister and end his career in infamy.

In 2004, Dimona Silica needed Olmert's help because the Investment Promotions Center's director, Shmuel Mordechai, had reservations about the viability of the venture. No viability, no grant, Mordechai said.

Dimona Silica's problems began when Olmert intervened and promised the venture a $10 million grant under the Law for the Encouragement of Capital Investments. Olmert's decision and conduct were subsequently placed under a magnifying glass.

Ultimately, Feinblum handed the reins of Dimona Silica to his son-in-law, Ronen Peled. "We never received most of the grant, and we survived only thanks to money from foreign investors," Peled told "Globes".

"One day, I was sitting in my office and looked at a poster of a car tire on the road, and wondered what would happen if we added silicate to the asphalt preparation process in order to extend the lifespan of tires. I, with no background in chemistry, thought that this would be either genius or idiocy. I didn’t know then that this idea would drive the company forward."

The company's Russian investors were skeptical. Peled said, "They laughed amongst themselves, saying in Russian, 'See, another one who thinks he's a chemist'. They did think I understood the ridicule."

Shortly afterwards, chemical experts from the Technion came to Dimona Silica's plant for a detailed briefing of the concept. They said that it was necessary to examine the mix and its durability, read the professional literature, and work long hours in the lab.

The initial results came a year later, and the news was good. The new additive, which is based on a mineral deposit found only at Nahal Zinn in the Negev and nowhere else in the world. The additive can double the lifespan of an asphalt road, make the driving experience quieter. The asphalt preparation process is more environmentally friendly than regular asphalt because there was no need to heat the asphalt to a high temperature and it cuts emissions of pollutants by 30%. The result is a substantial reduction in costs.

Dimona Silica moved quickly, registered a global patent for its iBind Mix, conducted a series of intensive tests, and paved roads in field tests under the supervision of the Israel Standards Institution.

The Russian investors were regularly updated on the developments, and sent back comments that only satisfied people make.

Peled said, "A crust formed over the wound. The Investment Promotions Center scandal almost killed us, even though we had nothing to do with it. Who would have believed it; we got back on our feet. We're now looking forward, we want to think about the past as little as possible, especially the bad parts."

Dimona Silica has already won its first tender, worth $6 million, to pave a road in China. After the pilot on the first road paved with iBind Mix in Israel, Peled said, "This was a historic moment. The mix was perfect. Everyone who drives on this stretch of road will feel the difference. There is simply no noise."

Dimona Silica is now talking about innovative and breakthrough products based on its proprietary mix and about global markets, ongoing tests of its mix in Europe and the US, and the company's new factory that will be built within four months in Dimona. The new plant will have a production line and employ at least 50 more people, residents of the Negev.

"The sky's the limit. We've got something and we have no intention of missing it," says Peled. "We have more obstacles to pass. We never received most of the government grant. Now that the material is shown to work and is viable from any perspective, there is no reason not to release the money to us. There is no reason for not building here the first production line of the chemicals products industry in Israel for export. We have something to offer, and it will only do good for Dimona and the south."

Bethel Finances: Bank of Israel reports lower inflation expectations

wwwbethelfinance.com

Bethel Finance news:

The Bank of Israel has cut current 12-month inflation expectations calculated from the capital market (through March 2012) to 3.3% from 3.7% in March. Current inflation expectations for the subsequent 12-month period (through March 2013) have fallen to 3% from 3.2% in March.

Current inflation expectations for the 12 months through March 2014 are down to 2.6% from 2.7% in March.

The average 12-month inflation expectations of banks and investment houses is unchanged at 3.1%, the same as in March and February.

Although the 12-month inflation expectations are still above the government's 1-3% inflation target, they are falling closer to the upper limit as the Consumer Price Index (CPI) rose 0.2% in March, in line with capital market forecasts.

Analysts believe that it will raise the interest rate by 25 basis points to 3.25%

Bethel Finances: Bank of Israel plans new series of coins

www.bethelfinance.com

Bethel Finance news:

The Bank of Israel is also considering ending use of the term "New Israeli Shekel", and reverting to the previous name of "Shekel".


The Bank of Israel is planning a new series of coins, 25 years after issuing the current series. The new coins will enter circulation within 2-3 years.

The reasons for the new coins to prevent forgery, reduce production costs, and to refresh the currency after a generation. Current production costs of the 10 agorot and 50 agorot coins are almost equal to their nominal value.

The new coins will have a completely different design from the current ones. No decision has yet been taken on the new designs, or how many coins will be issued. Most likely the same six denominations - 10 agorot, 50 agorot, NIS 1, NIS 2, NIS 5, and NIS 10 - will be issued under the new series.

The Bank of Israel is also considering ending use of the term "New Israeli Shekel", and reverting to the previous name of "Shekel". The New Israeli Shekel replaced the shekel in 1985, lopping off three zeros, during Israel's era of hyperinflation.

Bethel Finances: Gasoline prices set to rise again next week

www.bethelfinance.com

Bethel Finance news:

The rise in the price of gasoline will continue at the end of the month when prices in Israel are expected to rise by NIS 0.10-15 per liter, Channel 2 News reports.

If this forecast is realized then the maximum government controlled price of a liter of 95 octane at full service pumps in Israel could reach nearly NIS 7.70.

Part of the rise will be due to an update in excise, which will push up prices by NIS 0.03 per liter.

The main reason for the rise is the increasing cost of oil on world markets. On Wednesday alone the price of a barrel of crude oil in New York rose by 2.8% to $111.23.

A mitigating factor in moderating the rise in gasoline prices in Israel has been the strengthening of the shekel against the dollar. The US currency is at a 30-month low against the shekel.

Bethel Finances: Teva continues to fall

www.berthelfinance.com

Bethel Finance news:

The Tel Aviv Stock Exchange (TASE) rose today. The Tel Aviv 25 Index rose 0.20% to 1,341.89 points, the Tel Aviv 100 Index rose 0.41% to 1,221.59 points, and the TechBlue 50 Index rose 1.65% to 292.58 points. Turnover was NIS 946.2 million.

The Tel Aviv 25 Index set a new record today, breaking the previous all-time high set on January 19. The market is up 130% from the low point of 592.07 points reached in November 2008, and up 11% over the past year. The Tel Aviv 25 Index rose 1.2% for the week.

Turnover was thin because of the short session. The TASE will reopen next Tuesday, after the second Passover holiday.

In the bond market, long-term Shahar unlinked government bonds rose by up to 0.1%, and long-term Galil CPI-linked bonds ranged between losses of 0.1% and gains of 0.1%. The corporate bond benchmark Tel-Bond 20 Index fell 0.07%.

In the foreign currency market, the shekel-dollar representative exchange fell 0.56% to NIS 3.405/$, but the shekel-euro representative exchange rate rose 0.84% to NIS 4.984/€.

In the stock market, NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) rose 1.6% for the biggest gain among Tel Aviv 25 shares, followed by Israel Chemicals Ltd. (TASE: ICL), which rose 1.3% on the day's second largest turnover of NIS 79.6 million.

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) was the biggest loser, falling another 1.7% on the day's largest turnover of NIS 87.6 million. The TASE closed before news that Biogen Idec Inc. (Nasdaq: BIIB) announced positive results in the Phase III clinical trial of its multiple sclerosis treatment, which sent Teva's share price tumbling in premarket trading on Nasdaq.

In the oil and gas exploration sector, Israel Financial Levers Ltd. (TASE:LVR) rose 3.4% after announcing estimates of oil reserves at the Shemen license. Givot Olam Oil Exploration LP (TASE:GIVO.L) rose 9.5% and Israel Opportunity Energy Resources LP (TASE: ISOP.L) rose 7.1% without any announcements by either company.

Among technology shares, Mellanox Technologies Ltd. (Nasdaq:MLNX; TASE:MLNX) rose 5% and EZchip Semiconductor Ltd. (Nasdaq: EZCH; TASE:EZCH) rose 8.4% on positive arbitrage gaps.

Among small-cap shares, real estate company Netz Bonds (2009) Ltd. (TASE:NETZ) rose 24% for the week, despite a 0.6% dip today after announcing last week that its controlling shareholders will transfer theirs stakes in Africa-Israel Hotels Ltd. to the company.

Bethel Finances: Work begins on largest private power station

www.bethelfinance.com

Bethel Finance news:

Scotland-based Wood Group plc (LSE: WG) has begun construction of Israel's largest private power station that Dorad Energy Ltd. is establishing on land owned by Eilat Ashkelon Pipeline Company Ltd. (EAPC) in Ashkelon. The $870 million project is Wood Group's first activity in Israel.

Wood Group will carry out the earthworks, frame, construction, and electrical work for the power station. Wood Group GTS, the company's gas turbine services unit, will install the natural gas turbines, which are scheduled to arrive in Israel by the end of the year. The power station will have 12 General Electric gas turbines and two steam turbines.

The company will employee 300 people - mostly Israelis - on the project, and the number of employees will peak at 1,000 during the height of construction. Dorad shareholder Uri Dori Engineering Works Corp. (TASE: DORI) is the subcontractor for the earthworks.

Wood Group said that the power station will be completed in 2013. Wood Group Israel manager Shlomo Cohen said, "The company considers this project as a cornerstone for extensive operations in Israel. It considers construction of such a large project as a challenge and a breakthrough in the construction of power stations in Israel." He added, "This project is Wood Group's first project in Israel and Wood Group GTS intends to expand its operations in Israel in its areas of expertise."

Dorad is owned by EAPC (37.5%), Turkish conglomerate Zorlu Industrial and Energy Holding AS (25%), Adeltech Ltd. unit Adelcom Ltd. (18.75%), and Gazit-Globe Ltd. (TASE: GLOB) contracting arm Uri Dori U. Dori Energy Infrastructures Ltd. (18.75%). The company's 840-megawatt power station will cost NIS 4 billion and provide 8% of Israel's electricity. The company has a contract for natural gas with Egypt's East Mediterranean Gas Company

Bethel Finances: Teva tumbles on rival's favorable drug results

www.bethelfinance.com

Bethel Finance news:

The share price of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) tumbled 10% to $44.25 in premarket trading on the Nasdaq today after rival Biogen Idec Inc (Nasdaq: BIIB) reported positive data from its Phase III clinical trial of its oral multiple sclerosis drug, BG-12, and shares jumped 21 percent in premarket trading on Thursday. BG-12 is a rival to Teva's Laqunimod.

Biogen Idec's soared 26.5% in premarket trading to $109.50, giving cap of $20 billion.

The last time that Teva's share traded at $45 was in May 2009, during the rally that began in March 2009 following the global financial crisis.

In the conference call following the financial report for the first quarter, Biogen executives said that BG-12 cut the proportion of patients who relapsed by 49% and reduced the rate of progression by 38T percent after two years compared with placebo.

Clal Finance analyst Jonathan Kreizman told "Globes", "For a long time, Teva has been building market expectations that Laquinimod will be a dominant drug in its field. Today's information shows that it has a worthy rival in addition to Gilenya, developed by Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ).

Biogen sells two drugs that compete against Teva's Copaxone: Avonex and Tysabri (jointly owned by Ireland's Elan Corporation plc’s (NYSE: ELN; ISE: DRX). Biogen's BG-12 will complete against Laquinimod, which is due to reach market in 2012.

Copaxone had over $3 billion in sales in 2010, accounting for a third of Teva's profits. The map of multiple sclerosis treatments is changing as oral drugs come on the market and Copaxone will likely lose its high standing.

At the 63rd American Academy of Neurology (AAN) conference in Honolulu earlier this month, Biogen presented positive data about BG-12, as did Teva about Laquinimod. Today, Biogen CEO Dr. George Scangos was optimistic about BG-12, mentioning the positive results in the clinical trial.

It seems that investors considered Scangos' optimism as reason to be worried about Teva. Bernstein Research analyst Roni Gal said that the good results of BG-12 puts it in a good position against Laquinimod and other oral multiple sclerosis drugs. He said that BG-12 results were close to those achieved by Novartis's Gilenya, which is already on the market. However, he is cautious about the lack of safety profiles for the drug, and he believes Laquinimod will find its place in the market.

According to Biogen's financial report, Avonex had $642.5 million in sales in the first quarter and Tysabri had $251.4 million.

Teva will publish its financial report for the first quarter on May 11.

Teva's share price fell 1.7% on the TASE today to NIS 165.50, before Biogen Idec's announcement.

Wednesday, April 20, 2011

Bethel Finances: Shekel weakens against dollar despite US woes

www.bethelfinance.com

Bethel Finance news:
The shekel weakened against the dollar but strengthened against the euro in early inter-bank trading today. The shekel-dollar exchange rate rose 0.26% to NIS 3.425/$ and the shekel-euro exchange rate fell 0.28% to NIS 4.934/€

In international markets, the dollar is traded against the euro at $1.438/€ and at ¥82.88/$ against the Japanese yen.

Trading in the dollar is taking place against S&P's dramatic downgrade of US debt outlook to "Negative" on Monday. US stock markets fell on the news, but recovered after Treasury Secretary Timothy Geithner said that there was no chance that the US would loose its AAA debt rating.

On Sunday, the Bank of Israel will announce its interest rate decision for May. Analysts believe that it will raise the interest rate by 25 basis points to 3.25% because of inflation expectations.

Banks believe that the shekel-dollar exchange rate will continue to flounder this week on thin trading during the Passover holiday week and because they do not expect the Bank of Israel to intervene in the foreign currency market at this time.

Bethel Finances: Dankner signs Ma'ariv debt settlement

www.bethelfinance.com

Bethel Finance news:
Nochi Dankner has agreed to a debt settlement for Ma'ariv Holdings Ltd. (TASE: MARV-M), the owner of Hebrew daily "Ma'ariv". Discount Investment Corporation (TASE: DISI), through which Dankner controls Ma'ariv, signed a special agreement with Ma'ariv's creditor, Bank Hapoalim (TASE: POLI) for debt settlement on Sunday.

According to Discount Investment's notice to the TASE, Ma'ariv owes Bank Hapoalim NIS 106 million. Discount Investment will pay the bank NIS 42 million, plus interest, when the company closes its investment in Ma'ariv, and the bank will clear all of Ma'ariv's debt to it.

Ma'ariv's shareholders have to approve the settlement before the investment agreement is closed by August 22.

Discount Investment also signed an agreement with Ma'ariv's trustees to buy two million shares (1.8% of the company) for $2 million. The company also promised the bank that it would try to buy Vladimir Gusinski's 4.2% stake in Ma'ariv - 4.7 million shares, which are held by trustees - for $6 million..

The settlement between Discount Investment and Bank Hapoalim is a condition for Dankner to invest in Ma'ariv.

Trading in Ma'ariv's share was suspended at NIS 3.59, giving a market cap of INS 130 million, and will resume at 11:00.

Bethel Finances: Medical device co Applisonix in talks to sell CureLight

www.bethelfinance.com

Bethel Finance news:

Ultrasonic depilatory device maker Applisonix Ltd. (TASE:APLS) is in talks to sell subsidiary CureLight Ltd. and a pilot of its products to Hong Kong-based Navigator Ventures Group Ltd. In a notice to the TASE, Applisonix said that it signed a letter of intent with Navigator to conduct due diligence on CureLight, after which Navigator has the right to invest $2.3 million in CureLight for a 51% stake in the company.

CureLight has developed photodermatology products that use light-based treatments for acne and other common skin ailments. The products are certified by the US Food and Drug Administration (FDA) and other national regulators. In late 2008, Applisonix bought CureLight from Medtechnica Ltd. (TASE: MEDI) for $1.3 million, plus assumption of the company's $1.5 million debt. Applisonix also accepted CureLight's liabilities of up to $1.65 million to its receiver.

CureLight will use Navigator's investment - assuming it is made - to develop new models of its current products. If the new versions meet the parameters set out in the characterization document, Navigator will to buy the rest of CureLight for up to $3 million.

If Navigator and Applisonix do not reach agreement on the wording of the characterization document, Navigator has the right to acquire all of CureLight for $2 million.

Applisonix's share price fell 3.3% todayto NIS 0.68, giving a market cap of NIS 38 million.

Bethel Finances: Playtech about to acquire Ash Gaming - report

www.bethelfinance.com

Bethel Finance news:

"eGaming Review" reports that Playtech Cyprus Ltd. (AIM:PTEC) is in the final stages of acquiring Ash Gaming Ltd., a developer of casino games, for an undisclosed amount.

London-based Ash Gaming was founded in 2002, "delivering specific custom projects for customers in the early online gaming market," according to its website. Customers include 888 Holding plc (LSE:888), Playtech partner William Hill plc (LSE: WMH), Virgin Games Ltd., Gala Casino Ltd., and Betfred Bingo Ltd.

Ash Gaming uses Playtech's Gaming Technology Solutions (GTS) EdGE platform to provide several clients with its games.

If Teddy Sagi-controlled Playtech acquires Ash Gaming, it will be Playtech's eighth acquisition since it became a public company, and its seventh acquisition within two years. The company's M&A activity demonstrates more than just in-house growth. However, the effectiveness of the strategy is still hard to judge given the short time since the acquisitions.

Playtech's share price was unchanged at ₤3.34 in morning trading on the London Stock Exchange today, giving a market cap of ₤810 million. The share price has fallen 32% in the past year. Trading in the share has been volatile lately following the closing of websites of Pokerstars Ltd. and two other companies.

Bethel Finances: Tel Aviv 25 closes one point below record

www.bethelfinance.com

Bethel Finance news:
The Tel Aviv Stock Exchange (TASE) rose today. The Tel Aviv 25 Index rose 0.36% to 1,339.18 points, the Tel Aviv 100 Index rose 0.46% to 1,216.65 points, and the TechBlue 50 Index rose 0.36% to 285.70 points. Turnover was NIS 1.12 billion.

The Tel Aviv 25 Index is now just one point below its all-time high. The market closed at 2:45 pm, and will close at the same time tomorrow, for the Passover holiday.

In the bond market, both long-term Shahar unlinked government bonds and long-term Galil CPI-linked bonds rose by up to 0.3%. The corporate bond benchmark Tel-Bond 20 Index rose 0.02%.

In the foreign currency market, the shekel-dollar representative exchange rate rose 0.23% to 3.424/$, and the shekel-euro representative exchange rate fell 0.12% to NIS 4.942/€.

In the stock market, Israel Chemicals Ltd. (TASE: ICL) rose 3.8% for the biggest gain among Tel Aviv 25 shares, and help pull up its parent company, Israel Corporation (TASE: ILCO) by 2.7%.

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) fell 1.9%, for the biggest drop among Tel Aviv 25 shares, on the day's largest turnover of NIS 131 million.

The big five banks were the focus of attention, after Moody's Investment Services downgraded their deposits. Nonetheless, Bank Hapoalim (TASE: POLI) rose 0.8% and First International Bank of Israel (TASE: FTIN), which is on the Tel Aviv 100 Index, rose 0.3%. Bank Leumi (TASE: LUMI) fell 0.1%, Mizrahi Tefahot Bank (TASE:MZTF) fell 1.3%, and Israel Discount Bank (TASE: DSCT) fell 1%.

IDB Holding Corp. Ltd. (TASE:IDBH) holding company Discount Investment Corporation (TASE: DISI) rose 0.4% after announcing a debt settlement with Bank Hapoalim and Vladimir Gusinski, ahead of its pending acquisition of control of Ma'ariv Holdings Ltd. (TASE: MARV-M).

Silicom Ltd. (Nasdaq:SILC; TASE:SILC) rose 7.8% ahead of tomorrow's publication of its financial report for the first quarter.

Bethel Finances: Moody's downgrades 5 Israeli banks

www.bethelfinance.com

Bethel Finance news:

Moody's Investors Services has downgraded the deposit ratings of Israel's five largest banks by one level because it feels their profitability will remain weak due to rigid cost bases.

Moody's cut the deposit rating of Bank Hapoalim (TASE: POLI), Bank Leumi (TASE: LUMI), and Mizrahi Tefahot Bank (TASE:MZTF) to A2 from A1. It cut the ratings of Israel Discount Bank (TASE: DSCT) and First International Bank of Israel (TASE: FTIN) to A3 from A2.

Moody's said that the banks’ “moderate earnings-generating capacity prevents significant capital build-up which, in turn, hinders loss- absorption capacity.” Their capacity to absorb losses is hampered by their highly concentrated loan books, and concerns over the performance of the housing market.



Bethel Finances: Israel Corp. unit reports biomass fuel breakthrough

www.bethelfinance.com

Bethel Finance news:

Primus Green Energy Ltd., a US subsidiary of Israel Corporation's (TASE: ILCO) renewable energy unit IC Green Energy Ltd., reports that it has developed a process to convert agricultural biomass into standard automotive fuels at a competitive production cost compared with the price of oil. Primus GE uses agricultural residues that do not compete with food crops.

The final product is 93 octane gasoline, with the energy capabilities and characteristics of regular gasoline for vehicles and industry. There is no need for engine customization and can use existing fuel distribution networks. Primus GE says that its biofuel emits 80% less pollution than gasoline refined from oil.

As part of Primus GE's effort to commercialize its product, it has an engineering services agreement with Lockheed Martin Company (NYSE: LWT), which is seeking biofuel solutions, especially for jet fuel, for the US Department of Defense. Primus GE plans to produce bio-jet fuel.

Primus GE is also negotiating a letter of intent with a major US engineering company to be the chief contractor to build Primus GE's commercial plant.

The company has a cooperation agreement with New York-based Landmark Ventures to lead a future financing round. It also has a letter of intent from Tennessee-based Eco Energy Inc., which currently handles 20% of US ethanol and biodiesel commerce, and it is in contact with US agricultural companies to grow biomass on marginal land, and with logging companies for their wood residue.

Primus GE CEO Dr. Moshe Ben-Reuven founded the company and its chairman, Dr. Yom-Tov Samia is the president, IC Green Energy. Samia said today, "Primus GE can produce 2,000 gallons of biofuel at its pilot facility."

Samia added, "Primus GE's technology could lead to a positive revolution in the fuel industry, and signals a possible rehab from dependence on oil. IC Green Energy was founded in 2007 on the basis of Idan Ofer's vision to enter the renewal energy field. Fuel production from wood residue is another aspect of this strategy."

IC Green Energy operates worldwide, including solar energy in Israeli and biofuel development in Germany. Israel Corp, controlled by the Ofer family, invested $105 million in IC Green Energy through the end of 2010.

Bethel Finances: UK co Expro wins $27m Tamar drilling contract

www.bethelfinance.com

Bethel Finance news:

Expro will provide Noble Energy with specialist well testing and deep sea services and equipment.

Noble Energy Inc. (NYSE: NBL) has awarded a $27 million contract to UK company Expro International Group Ltd. for deep-sea drilling operations.

Expro will implement development operations for drilling the Tamar gas field using the Sedco Express rig, and will also be involved in Noble Energy's exploration plans using the Pride North America rig. The Tamar gas field is off the coast of Hadera.

Expro will provide Noble Energy with specialist well testing and deep sea services and equipment, including a high flow rate well testing package and large bore subsea safety systems.

Expro has a proven track record of providing custom-designed solutions for the oil and gas industry and offers a comprehensive package of support services and products for exploration stage drilling and investigations in assessing discoveries. The company is active in deep water energy exploration projects worldwide in Africa, the Gulf of Mexico and Brazil.

This is the largest contract ever signed by Expro in the Mediterranean region and represents a significant expansion by the company in the region.

Expro Europe CIS regional director Keith Palmer said: “Expro’s track record in deep water means we are well positioned to move in to new markets and bring the benefits of our leading-edge technologies to our customers. This is a significant win for Expro’s Continental Europe team.”

Tuesday, April 19, 2011

Bethel Finances: Cabinet Allocates NIS 19 Billion to Move IDF Units to the Negev

www.bethelfinance.com

Bethel Finance news:

The Cabinet today approved the allocation of NIS 19 billion for transferring IDF bases from the center of the country to the Negev. The move will continue until 2018. Intelligence Corps units and bases will move to the Lakit-Omer installation; communications bases will move to the scientific park in Be'er Sheva.

Financing for the move will be as follows: The Finance Ministry will allocate NIS 9 billion, and the Defense Ministry NIS 4 billion. The remaining NIS 6 billion will be provided for from returns on the marketing of the lands of the evacuating bases in the center of the country.

The move will evacuate land in the center of the country upon which it will be possible to build tens of thousands of housing units. This will facilitate the creation of thousands of new jobs and the transfer of quality populations to the Negev where they will contribute to the social development of the area.

The Government approved the project of moving IDF units in 2005, but the heart of the move – Intelligence Corps and communication units – was delayed due to a disagreement between the relevant ministries over the size and sources of the necessary budgets. Today's decision will enable these units to move south.

The process of transferring IDF bases to the Negev is in keeping with the Government's goals of advancing and strengthening the periphery and its previous decision to allocate NIS 27 billion to the national roads project, in the framework of which highways and rail lines to the Negev will be expanded.

Prime Minister Netanyahu said that, "This historic step will greatly contribution to the IDF and the security establishment, as well as to the Negev and its residents. My Government will continue to act to strengthen the Negev and the Galilee with national projects in the spheres of transportation, construction, infrastructures, community settlement, employment, education and any sphere that will advance and strengthen these areas."

Bethel Finances: Billionaires Flourish, Inequalities Deepen as Economies “Recover”

www.bethelfinance.com

Bethel Finance news:

In this profile of global wealth accumulation, James Petras illustrates the direct link between the exponential increase of the U.S. super rich in recent years and the tanking real economy. Unsurprisingly, the prize for the fastest and most dramatic growth of new billionaires goes to the BRIC block countries - recently joined by South Africa - but much to the detriment of their working classes and environment.The bailouts of banks, speculators and manufacturers served their real purposes: the multi-millionaires became billionaires and the latter became multi-billionaires.
Introduction

According to the annual report of the business magazine Forbes there are 1,210 individuals – and in many cases family clans – with a net value of $1 billion dollars (or more). There total net worth is $4 trillion, 500 billion dollars, greater than the combined worth of 4 billion people in the world. The current concentration of wealth exceeds any previous period in history; from King Midas, the Maharajahs, and the Robber Barons to the recent Silicon Valley – Wall Street moguls of the present decade.

An analysis of the source of wealth of the super-rich, the distribution in the world economy and the methods of accumulation highlights several important differences with major political consequences. We will proceed to identify these specific features of the super-rich, starting with the United States and follow with an analysis of the rest of the world.

The Super-Rich in the US: Greatest Living Parasites

The US has the most billionaires in the world (413), better than one third of the total, the greatest proportion among the “big countries" in the world. A closer look also reveals that among the top 200 billionaires (those with $5.2 billion and more) there are 57 from the US (29%). Over one third made their fortune through speculative activity, predators on the productive economy and exploiters of the property and stock market. This is the highest percentage of any major country in Europe or Asia (with the exception of England). The enormous concentration of wealth in the hands of this tiny parasitical ruling class is one reason why the US has the worst inequalities of any advanced economy and among the worst in the entire world.

Speculators do not employ workers, they secure tax loopholes and bailouts and then press for cuts in the social budget, since they do not require a healthy, educated workforce (except for a tiny elite). In 1976 the top 1% held 20% of the wealth; in 2007 they commanded 35% of total wealth. Eighty percent of Americans own only 15% of the wealth. The recent economic crises, which initially reduced the total wealth of the country, did so in an uneven fashion – hitting the majority of workers and employees worse.

The Bush-Obama bailout led to the economic recovery, not of the “economy in general”, but was confined to further enhancing the wealth of the billionaires – which explains why the unemployment/under employment rate has hardly moved, why the fiscal debt and trade deficit grows and the state lowers corporate taxes and slashes federal, state and municipal budgets.

The “dynamic” sector composed of parasitical capitalists employs few workers, exports no products, pays lower taxes and imposes greater cuts in social spending for productive workers. In the case of the US billionaires, their wealth is largely accrued via the pillage of the state treasury and productive economy and via speculation in the information technology sector which houses one-fifth of the top billionaires.

BRIC’s: The New billionaires: Exploiting Labor of Nature

The leading emerging capitalist countries, Brazil, Russia, India and China (BRIC) hailed by the mass media for their rapid growth over the past decade are producing billionaires at a faster rate than any bloc of countries in the world. According to the latest data in Forbes (March 2011), the number of billionaires in the BRICs increased over 56% from 193 in 2010 to 301 in 2011, exceeding that of Europe.

The high growth of the BRICs - has led to the concentration and centralization of capital, in every case promoted by state policies which provides low interest loans, subsidies, tax incentives, unrestricted exploitation of natural resources and labor, the dispossession of small property owners and the give-away of publically owned enterprises.

The dynamic growth of billionaires in the BRICs has led to the most egregious inequalities in the world. Among the BRICs, China leads the way with the greatest number of billionaires (115) and the worst inequalities in all of Asia, in sharp contrast to its Communist past when it was the most egalitarian country in the world. An examination of the source of wealth of China’s super rich reveals that it has resulted from the exploitation of labor in the manufacturing sector, speculation in real-estate and construction and trade. China has surpassed the US as the world’s biggest manufacturer in 2011, as a result of the super-exploitation of labor in China and the growth of parasitical financial capital in the US.

In contrast to the US, China’s working class is making significant inroads into the profiteering of its manufacturing and real estate elite. As a result of working class struggle, wages have been growing between 10% and 20% over the past 5 years; protests by farmers and urban households against state sanctioned evictions by real estate speculators have exceeded 100,000 per year.

The wealth of Russian billionaires on the other hand resulted from the violent theft of public resources (oil, gas, aluminum, iron, steel, etc.), developed by the previous Communist regime. The great majority of Russian billionaires depend on the export of commodities, pillaging and devastating the natural environment under a corrupt and deregulated regime. The contrast in living and working conditions between the western oriented billionaires and the Russian working class is largely the result of the siphoning off of wealth to overseas accounts, offshore investments and extraordinary personal luxuries including multi-million dollar real estate. In contrast to China’s industrial elite, Russia’s billionaires resemble the parasitical ‘rentiers’ found among Wall Street speculators and Persian Gulf sheiks.

India’s billionaires are a combination of old and new rich drawing their wealth by exploiting low wage industrial workers, dispossessing slum and tribal peoples, as well as from diversified holdings in real estate, IT and software. India’s billionaires accumulated their wealth through their class-kin linkages to the very corrupt higher echelons of the political class, securing monopolies via state contracts. India’s high growth over the past decade (averaging 7%) and the upsurge in billionaires upward to 55 by 2011, are both linked the neo-liberal policies of deregulation, privatization and globalization, which have concentrated wealth at the top, undermined small scale producers and dispossessed tens of millions.

Brazil’s billionaire class has expanded rapidly, especially under the leadership of the Workers Party, to 29, up from single digits a decade earlier. Today over two-thirds of Latin America’s billionaires are Brazilians. The centerpiece of Brazil’s super rich wealth is the financial-banking sector which has benefited enormously from the monetary, fiscal and neo-liberal policies of the Lula Da Silva regime. Billionaire bankers have been the principle beneficiaries of the agro-mineral export economy which has flourished over the past decade, at the expense of the manufacturing sector. Despite claims by Workers Party leaders, the class inequalities between the mass of minimum wage workers ($380 per month as of March 2011) and the super-rich continues to be worst in Latin America. An analysis of the source of wealth among Brazilian billionaires reveals that 60% accrued their wealth in the finance, real estate and insurance (FIRE) sector and only one (3%) in the capital or intermediary maufacturing sector.

Brazil’s boom in economic growth and billionaires fits the profile of a ‘colonial economy’: heavy in conspicuous consumption, commodity exports and presided over by a dominant financial sector which promotes neo-liberal policies. Over the course of the past decade despite the populist political theatrics and paternalistic poverty-programs sponsored by the “center-left” Workers Party, the major socio-economic outcome has been the growth of a class of “super-rich” billionaires concentrated in banking with powerful links to the agro-mineral sectors. The free-market high growth financial-agro-mineral class has degraded the manufacturing sector, especially textiles and shoes, as well as capital and intermediary goods producers.

The BRICs are producing more, and growing faster than the established imperial powers in Europe and the US but they are also producing monstrous inequalities and concentrations of wealth. The socio-economic consequences have already manifested themselves in increasing class conflict especially in China and India, as intensive exploitation and dispossession have provoked mass action.

The Chinese political elite seems to be the most conscious of the political threat posed by the growing concentration of wealth and is in the midst of promoting substantial wage increases and greater local consumption which seems to be lowering profit margins among some sectors of the manufacturing elite. Perhaps the ‘historical memory’ of the “cultural revolution’ and the Maoist legacy plays a role in alerting the political elite to the political dangers resulting from “capitalist excesses” associated with the high levels of exploitation and the rapid growth of a class of politically connected kinship based billionaires.

Middle East

Over the past decade the most dynamic country in the Middle East has been Turkey. Led by a liberal democratic regime of Islamic inspiration, Turkey has led the region in GDP growth and in the production of billionaires. The Turkish economic performance has been presented by the World Bank and the IMF as a model for the post dictatorial regimes in the Arab world – ‘high growth’, a diversified economy based on the growing concentration of wealth. Turkey has 35% more billionaires (37) than the Gulf and North African states combined (24).

The ‘secret’ of Turkish growth is the high rates of investments in diverse industries and the intensive exploitation of labor. Many Turkish billionaires (14) derive their wealth via ‘conglomerates’, investments in diverse manufacturing, finance and construction sectors . Apart from the ‘conglomerate’ billionaires, there are ‘specialist billionaires’ who have accumulated wealth from banking, construction and food manufacturing. One of the reasons Turkey has rebuked and challenged Israeli power in the Middle East is because its capitalists are eager to project investments and penetrate markets in the Arab world. Apart from the highly Zionized US political system, the ruling elites and publics in Europe and Asia have looked favorably on Turkey’s opposition to Israel’s massacres in Gaza and violation of international law on the high seas.

If a modern liberal Islamic regime can grow rapidly through the rapid expansion of a diversified class of the super-rich, so does Israel, a modern neo-liberal-Judaic state based on the rapid growth of a highly diverse class of billionaires. Israel with 16 billionaires is a country with the fastest growing class inequalities in the region-with the highest per-capita billionaires in the world… Israel’s “growth sectors”, software, military industries, finance, insurance and diamonds and overseas investments in metals and mining are led by billionaires and multi-millionaires who have benefited from Zionist induced financial handouts from the US pillage of resources from the ex-USSR and transfer of funds by Russian-Israeli oligarchs and though joint ventures with Jewish-American billionaires in software corporations, especially in the “security” sector.

Israel’s high percentage of billionaires at a time of sharp cuts in social spending puts the lie to its claim to be a ‘social democracy’ in the midst of Arab ‘sheiksdoms.’ As a matter of record, Israel has twice as many billionaires (16) as Saudi Arabia (8) and more super-rich than the entire Gulf countries (13). The fact that Israel has more billionaires per capita than any other country has not prevented its Zionist supporters in the US from pressing for additional 20 billions in aid over the next decade.

Unlike the past, today Israel’s wealth concentration has less to do with its being the biggest recipient of foreign aid ... Israel’s handouts is a political issue: Zionist power over the Congressional purse. Given the total wealth of Israel’s billionaires a five percent tax would more than compensate for any cut off of US foreign aid. But that is not about to happen simply because Zionist power in America dictates that the US taxpayers subsidize Israel’s plutocrats by paying for their offensive weaponry.

Conclusion

The “economic crises” of 2008-2009 inflicted only temporary losses to some (US-EU) billionaires and not others (Asian). Thanks to trillion dollar/Euro/yen bailouts, the billionaires class has recovered and expanded, even as wages in the US and Europe stagnate and ‘living standards’ are slashed by massive cutbacks in health, education, employment and public services.

What is striking about the recovery, growth, and expansion of the world’s billionaires is how dependent their accumulation of wealth is based on pillage of state resources; how much of their fortunes were based on neo-liberal policies which led to the takeover at bargain prices of privatized public enterprises; how state de-regulation allows for plunder of the environment to extract resources at the highest rate of return; how the state promoted the expansion of speculative activity in real estate, finance and hedge funds, while encouraging the growth of monopolies, oligopolies and conglomerates which captured “super profits” – rates above the ‘historical level’. Billionaires in the BRICs and in the older imperial centers (Europe, US and Japan) have been the primary tax beneficiaries of reductions and elimination of social programs and labor rights.

What is absolutely clear is that the state not the market plays a essential role in facilitating the greatest concentration and centralization of wealth in world history, whether in facilitating the plundering of the treasury and the environment or in heightening the direct and indirect exploitation of labor.

The variations in the paths to ‘billionaire’ status are striking: in the US and UK, the parasitical – speculative sector predominates over the productive; among the BRICs – with the exception of Russia diverse sectors incorporating manufacturers, software, finance and agro-mineral billionaires predominate. In China the abysmal economic gap between the billionaires and the working class, between real estate speculators and dispossessed household is lead to increasing class conflict and challenges, forcing significant increases in wages (over 20% the past 3 years) and demands for increased public spending on education, health and housing. Nothing comparable is occurring in the US, EU or in the other BRICs.

The sources of billionaire wealth are, at best, only partially due to ‘entrepreneurial innovations’. Their wealth may have begun, at an earlier phase, from producing useful goods and services; but as the capitalist economies ‘mature’ and shift toward finance, overseas markets and the search for higher profits by imposing neo-liberal policies, the economic profile of the billionaire class shifts toward the parasitical model of the established imperial centers.

The billionaires in the BRICs, Turkey and Israel contrast sharply from the Middle East oil billionaires who are ‘rentiers’ living off ‘rents’ from exploiting oil and gas and overseas investments especially in the FIRE sector. Among the BRICs only the Russian billionaire oligarchs resemble the rentiers of the Gulf. The rest, especially Chinese, Indian, Brazilian and Turkish billionaires have taken advantage of state promoted industrial policies to concentrate wealth under the rhetoric of ‘national champions’, promoting their own ‘interests’ in the name of a “successful emerging economy”.

But the basic class questions remains: “growth for whom and who benefits?”. So far the historical record shows that growth of billionaires has been based on a highly polarized economy in which the state serves the new class of billionaires, whether parasitical speculators as in the US, rentier pillagers of the state and environment such as Russia and the Gulf states or exploiters of labor such as in the BRICs.

Post Script

The Arab revolt can be seen in part as an effort to overthrow ‘rentier capitalist clans’. Western intervention in the revolts and support of the “opposition” military and political elites is an effort to substitute a ‘neo-liberal’ capitalist ruling class. This “new class” would be based on the exploitation of labor and dispossession of current crony-clan-kin owners of resources Major enterprises would be transferred to multi-nationals and local capitalists.

Much more promising are the internal working struggles in China and to lesser degree in Brazil and the rural based Maoist peasant and tribal movements in India which oppose rentier and capitalist exploitation and dispossession.